Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response

Table 1 Characteristics of gastric cancer patients n (%)

		CanPatrol
	All	Positive, n/total	P value
Median age, yr (range)	56 (25-87)
Gender			0.780
Male	31	25/31 (80.6)
Female	13	10/13 (76.9)
Post-TNM stage
Tumor			0.799
T1	11	9/11 (81.2)
T2	4	3/4 (75)
T3	5	4/5 (80)
T4	21	19/21 (90.5)
Node			0.710
N0	22	17/22 (77.3)
N+	19	18/19 (94.7)
Metastasis			0.115
M0	36	30/36 (83.3)
M1	5	5/5 (100)
Site of metastases
Peritoneal carcinosis	5	5/5 (100)
Histology			0.400
Adenocarcinoma	38	31/38 (81.6)
Signet-ring cell carcinoma	6	4/6 (66.7)
Lymphatic emboli			0.461
No	21	17/21 (81)
Yes	11	10/11 (90.9)
Her2			0.303
+++	2	2/2 (100)
++	7	7/7 (100)
+	12	11/12 (91.7)
0	20	15/20 (75)

T1: Tumor invades lamina propria or submucosa; T2: Tumor invades muscularis propria or subserosa; T3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures; T4: Tumor invades adjacent structures; N0: No regional lymph node metastasis; N+: Lymph node metastasis; M0: No distant metastasis; M1: Distant metastasis.